Trial record 1 of 1 for:
Personalized multimodal treatment for resectable esophageal cancer by detecting minimal residual disease using circulating tumor DNA: a multicentric prospective study
Liquid Biopsies in Esophageal Cancer
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05704530 |
|
Recruitment Status :
Recruiting
First Posted : January 30, 2023
Last Update Posted : April 10, 2023
|
Sponsor:
Universitaire Ziekenhuizen KU Leuven
Collaborator:
Kom Op Tegen Kanker
Information provided by (Responsible Party):
Universitaire Ziekenhuizen KU Leuven
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | September 30, 2025 |
| Estimated Study Completion Date : | December 31, 2026 |